Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

High TSPEAR levels in colorectal cancer predict worse outcomes.

Early diagnosis and treatment are crucial for complex medical conditions.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

A new type of pachyonychia congenita linked to a specific keratin gene mutation was found in two Pakistani families.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Men with X-linked recessive ichthyosis often experience male-pattern baldness.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Androgen receptor activity is influenced by hormones, co-factors, modifications, and mutations.

The IRE gene is important for normal root hair growth in Arabidopsis plants.

New genetic mutations causing hair loss were found in a Chinese family.

A new mutation in the KRT86 gene causes monilethrix in a Han family.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

Certain gene variations and irregular X chromosome activity may contribute to hair loss in women who can have children.

Higher RBP4 levels found in people with two types of hair loss.

5α-reductase enzymes are crucial in certain disorders, and while treatment advances exist, more research on SRD5A3 is needed.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Scientists created cell lines to study a genetic skin disorder using CRISPR technology.

The enzyme RDH12 plays a role in vision and retinal disease, with mutations leading to early onset visual loss and blindness, but the exact disease mechanism is unclear and there are no treatments yet.

KRT6A may help diagnose and treat alopecia areata.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Scientists created a cell model to study and find treatments for a skin disease called RDEB.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Retinoic acid helps change skin cells and is important for skin development and hair growth.